Skip to main content
. 2020 May 21;43(11):zsaa098. doi: 10.1093/sleep/zsaa098

Table 1.

Demographic and polysomnographic information of the study population

Whole population (n = 894) Training set (n = 715) Validation set (n = 90) Test set (n = 89)
Median (interquartile range)
Age (years) 55.9 (44.7–65.8) 55.8 (44.7–66.0) 56.6 (42.9–66.4) 56.1 (45.3–63.3)
ArI (1/h) 20.7 (13.9–31.4) 21.1 (14.1–32.5) 18.9 (13.2–26.6) 20.5 (13.6–29.5)
AHI (1/h) 15.8 (7.0–32.6) 16.0 (7.4–33.5) 12.3 (5.7–30.2) 16.8 (6.5–33.2)
BMI (kg/m2) 34.4 (29.4–40.4) 34.2 (29.3–40.1) 35.9 (28.6–41.5) 34.8 (31.1–41.2)
N1 (%) 10.9 (6.7–18.8) 11.1 (6.9–19.3) 10.8 (6.0–19.1) 9.7 (5.5–16.2)
N2 (%) 48.3 (41.2–56.2) 48.2 (41.6–56.5) 50.3 (40.3–55.2) 48.8 (38.5–55.6)
N3 (%) 18.3 (9.6–26.8) 18.0 (9.4–26.9) 17.7 (9.4–26.0) 20.4 (11.4–27.8)
NREM (%) 82.9 (77.8–88.1) 83.0 (77.8–88.1) 82.4 (78.5–88.8) 82.4 (77.1–86.4)
REM (%) 17.1 (11.8–22.0) 16.9 (11.8–22.2) 17.5 (11.0–21.4) 17.6 (12.5–22.8)
SE (%) 70.7 (58.1–81.9) 70.7 (57.9–81.7) 69.9 (55.2–83.6) 71.9 (60.1–80.7)
SL (min) 17.5 (9.0–34.5) 17.5 (9.5–35.1) 19.0 (7.0–29.8) 15.0 (9.0–33.5)
TRT (min) 442.3 (409.5–474.0) 442.0 (410.3–474.5) 449.0 (412.4–474.6) 438.0 (403.1–464.5)
TST (min) 308.8 (253.5–359.5) 309.5 (253.0–359.5) 304.0 (249.5–368.6) 304.0 (259.3–347.8)
WASO (min) 102.5 (61.0–149.5) 102.8 (61.0–152.0) 96.0 (60.6–144.4) 100.0 (65.4–135.8)
n (% of the population)
No OSA 154 (17.2) 117 (16.4) 20 (22.2) 18 (20.2)
Mild OSA 278 (31.1) 224 (31.3) 29 (32.2) 24 (27.0)
Moderate OSA 209 (23.4) 168 (23.5) 17 (18.9) 24 (27.0)
Severe OSA 253 (28.3) 206 (28.8) 23 (25.6) 24 (27.0)
Female 398 (44.5) 320 (44.8) 39 (43.3) 39 (43.8)
Male 496 (55.5) 395 (55.2) 50 (55.6) 51 (57.3)

ArI, arousal index; AHI, apnea-hypopnea index; BMI, body mass index; SE, sleep efficiency; SL, sleep latency; TRT, total recording time; TST, total sleep time; WASO, wake after sleep onset. No obstructive sleep apnea (OSA): AHI < 5, mild OSA: 5 ≤ AHI < 15, moderate OSA: 15 ≤ AHI < 30, severe OSA: AHI ≥ 30.